May 18, 2021 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Agenus TIGIT Deal Conference Call and Webcast. (Operator Instructions) Please note this event is being recorded and may be used in future Agenus promotional material. I would now like to turn the conference over to Jan Medina, Director of Investor Relations. Jan, please go ahead.
Jan Medina -
Thank you, Stacy, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay. Also for today's announcement, we have a very short slide deck available for those of you that are logged in and for those that are coming in for the replay that will be posted to our website later today.
I would also like to remind you that this call will include forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans and time lines as well as time lines for data release and partnership opportunities. These statements are subject to risks and uncertainties, and we refer you to our SEC filings for
Agenus Inc Discuss the Global Licensing Agreement Between Agenus and Bristol Myers Squibb - Corporate Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot